ALK-Abelló CEO Weighs In: Size Of Grastek® Bump Not Known-able, Yet

Just as we said yesterday — it may be tough to get a premium price here.

From Reuters, overnight:

. . . .The potential for Grastek, an oral allergy drug made by Denmark’s ALK Abello and American partner Merck, will depend on the product’s label and price in tihe United States, chief executive Jens Bager told Reuters on Friday. . . .



It may be material to ALK-Abelló — but not to Merck.


Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s